Clinical trials involving stem cell therapies present added complexity: the treatment requires cell preservation as it is collected from a patient or donor, shipped to a manufacturing site, modified, and then shipped to the treatment facility for patient administration. Learn how Calyx delivered an effective IRT solution that met the challenge and successfully enabled cell preservation during a stem cell therapy trial.

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.